Nelly T Fabre Selected Research

NF-kappa B p50 Subunit

1/2018

Advanced glycation end products-induced insulin resistance involves repression of skeletal muscle GLUT4 expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nelly T Fabre Research Topics

Disease

3	Inflammation (Inflammations) 04/2021 - 01/2017
3	Insulin Resistance 01/2018 - 01/2017
1	Body Weight (Weight, Body) 01/2017
1	Kidney Diseases (Kidney Disease) 01/2016
1	Fibrosis (Cirrhosis) 01/2016

Drug/Important Bio-Agent (IBA)

4	Advanced Glycation End ProductsIBA 04/2021 - 01/2017
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2017
3	Messenger RNA (mRNA)IBA 01/2018 - 01/2016
2	AlbuminsIBA 01/2018 - 01/2017
1	NF-kappa B p50 SubunitIBA 01/2018
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Glucose Transporter Type 4IBA 01/2018
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2017
1	LipidsIBA 01/2017
1	Liver GlycogenIBA 01/2017
1	Thiobarbituric Acid Reactive SubstancesIBA 01/2017
1	GlycogenIBA 01/2017
1	Dietary Advanced Glycation End ProductsIBA 01/2016
1	N(6)-carboxymethyllysine (carboxymethyllysine)IBA 01/2016
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 01/2016